NDC 65162-149

LYLLANA

Estradiol

LYLLANA is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Estradiol.

Product ID65162-149_17bf7bfa-b260-46cb-9a81-4ce798477a5b
NDC65162-149
Product TypeHuman Prescription Drug
Proprietary NameLYLLANA
Generic NameEstradiol
Dosage FormPatch, Extended Release
Route of AdministrationTRANSDERMAL
Marketing Start Date2020-09-30
Marketing CategoryANDA / ANDA
Application NumberANDA211396
Labeler NameAmneal Pharmaceuticals LLC
Substance NameESTRADIOL
Active Ingredient Strength0 mg/d
Pharm ClassesEstradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65162-149-08

8 POUCH in 1 CARTON (65162-149-08) > 1 d in 1 POUCH (65162-149-04)
Marketing Start Date2020-09-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LYLLANA" or generic name "Estradiol"

NDCBrand NameGeneric Name
65162-126LYLLANALYLLANA
65162-149LYLLANALYLLANA
65162-150LYLLANALYLLANA
65162-228LYLLANALYLLANA
65162-148LYLLANALYLLANA
0023-5885AloraEstradiol
0023-5886AloraEstradiol
0023-5887AloraEstradiol
0023-5888AloraEstradiol
0037-4801ELESTRINESTRADIOL
0037-4802ELESTRINESTRADIOL
0013-2150Estringestradiol
0078-0343Vivelle-Dotestradiol
0078-0344Vivelle-Dotestradiol
0078-0345Vivelle-Dotestradiol
0078-0346Vivelle-Dotestradiol
0078-0365Vivelle-Dotestradiol

Trademark Results [LYLLANA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LYLLANA
LYLLANA
88769420 not registered Live/Pending
Amneal Pharmaceuticals LLC
2020-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.